Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment

Justin Paget/DigitalVision via Getty Images Introduction Last year, I started covering Zoetis Inc. (NYSE:ZTS), the animal health-focused healthcare giant. My most recent article on this stock was written on January 10, when I went with the title "Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns."  Here's a part of my takeaway back then: Despite economic uncertainties, the company anticipates continued success in key franchises, projecting double-digit operational growth for the companion anima ...